Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E.
Raja SM, Guptill JT, Juel VC, Walter EB, Cohen-Wolkowiez M, Hill H, Sendra E, Hauser B, Jackson P, Tomic M, Espinoza Y, Swamy GK. Raja SM, et al. Among authors: hauser b. Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0173221. doi: 10.1128/aac.01732-21. Epub 2022 Mar 21. Antimicrob Agents Chemother. 2022. PMID: 35311524 Free PMC article. Clinical Trial.
Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.
Guptill JT, Raja SM, Juel VC, Walter EB, Cohen-Wolkowiez M, Hill H, Sendra E, Hauser B, Jackson P, Swamy GK. Guptill JT, et al. Among authors: hauser b. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0232920. doi: 10.1128/AAC.02329-20. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33875433 Free PMC article. Clinical Trial.
First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers.
Van Eldik LJ, Sawaki L, Bowen K, Laskowitz DT, Noveck RJ, Hauser B, Jordan L, Spears TG, Wu H, Watt K, Raja S, Roy SM, Watterson DM, Guptill JT. Van Eldik LJ, et al. Among authors: hauser b. Clin Pharmacol Drug Dev. 2021 Feb;10(2):131-143. doi: 10.1002/cpdd.795. Epub 2020 Apr 7. Clin Pharmacol Drug Dev. 2021. PMID: 32255549 Free PMC article. Clinical Trial.
Sequence Analysis of Inducible, Replication-Competent Virus Reveals No Evidence of HIV-1 Evolution During Suppressive Antiviral Therapy, Indicating a Lack of Ongoing Viral Replication.
Lee SK, Sondgeroth A, Xu Y, Warren J, Zhou S, Gilleece M, Hauser BM, Gay CL, Kuruc JD, Archin NM, Eron JJ, Margolis DM, Goonetilleke N, Swanstrom R. Lee SK, et al. Among authors: hauser bm. Open Forum Infect Dis. 2024 Apr 17;11(5):ofae212. doi: 10.1093/ofid/ofae212. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38756763 Free PMC article.
Allergy to an extensive rice hydrolysate. The first case report.
Vandenplas Y, De Greef E, Hauser B, Huysentruyt K. Vandenplas Y, et al. Among authors: hauser b. Acta Paediatr. 2024 May;113(5):1015-1016. doi: 10.1111/apa.17161. Epub 2024 Feb 13. Acta Paediatr. 2024. PMID: 38348723 No abstract available.
428 results